For people with heart disease who are already taking statins, taking a special slow-release niacin pill plus another pill called laropiprant for about 4 years can slightly lower their bad cholesterol by 10 points and raise their good cholesterol by 6 points.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim is precise in dosage, population, duration, and effect size, and mirrors the design and reporting of large randomized controlled trials such as HPS2-THRIVE, which tested this exact combination. The use of 'average' and 'median' reflects appropriate statistical reporting. The outcomes (LDL and HDL changes) are direct, measurable biomarkers, making a definitive statement acceptable when based on RCT data. However, the claim omits that this combination did not reduce cardiovascular events despite lipid changes, which is critical context but not required for the accuracy of this specific lipid-effect statement.
More Accurate Statement
“In adults with atherosclerotic vascular disease on statin therapy, extended-release niacin (2 g/day) with laropiprant (40 mg/day) reduces LDL cholesterol by an average of 10 mg/dL and increases HDL cholesterol by an average of 6 mg/dL over a median follow-up of 3.9 years.”
Context Details
Domain
medicine
Population
human
Subject
Adults with atherosclerotic vascular disease on statin therapy
Action
lowers... and raises
Target
LDL cholesterol by an average of 10 mg/dL and HDL cholesterol by an average of 6 mg/dL
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Effects of extended-release niacin with laropiprant in high-risk patients.
The study gave people the same pills mentioned in the claim and found that, yes, LDL went down by 10 and HDL went up by 6 — just like the claim said. It didn’t help them live longer or prevent heart attacks, but that’s not what the claim was about.